Reviewed,
UniProtKB/Swiss-Prot Q9GZV9 (FGF23_HUMAN)
Last modified
June 16, 2009.
Version 95.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Fibroblast growth factor 23 Short name=FGF-23 Alternative name(s): Tumor-derived hypophosphatemia-inducing factor Phosphatonin Cleaved into the following 2 chains: 1- Recommended name: Fibroblast growth factor 23 N-terminal peptide 2- Recommended name: Fibroblast growth factor 23 C-terminal peptide | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 251 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Subcellular location | |
| Post-translational modification | After secretion it is processed into a N-terminal fragment and a C-terminal fragment. The processing is effected by the proprotein convertases. |
| Involvement in disease | Defects in FGF23 are the cause of autosomal dominant hypophosphataemic rickets (ADHR) [MIM:193100]. ADHR is characterized by low serum phosphorus concentrations, rickets, osteomalacia, leg deformities, short stature, bone pain and dental abscesses. Ref.2 Defects in FGF23 are a cause of hyperphosphatemic familial tumoral calcinosis (HFTC) [MIM:211900]. HFTC is a severe autosomal recessive metabolic disorder that manifests with hyperphosphatemia and massive calcium deposits in the skin and subcutaneous tissues. Ref.12 |
| Sequence similarities | Belongs to the heparin-binding growth factors family. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Secreted |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | Signal |
| Molecular function | Growth factor |
| PTM | Disulfide bond |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cell differentiation Non-traceable author statement. Source: UniProtKB fibroblast growth factor receptor signaling pathwayInferred from Experiment. Source: Reactome |
| Cellular component | extracellular space Non-traceable author statement. Source: UniProtKB |
| Molecular function | growth factor activity Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 24 | 24 | Ref.7 | |||||||||||||||||||||||||||||||||||||||||
| Chain | 25 – 251 | 227 | Fibroblast growth factor 23 | PRO_0000008998 | ||||||||||||||||||||||||||||||||||||||||
| Chain | 25 – 179 | 155 | Fibroblast growth factor 23 N-terminal peptide | PRO_0000352875 | ||||||||||||||||||||||||||||||||||||||||
| Chain | 180 – 251 | 72 | Fibroblast growth factor 23 C-terminal peptide | PRO_0000352876 | ||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||
| Site | 179 – 180 | 2 | Cleavage; by proprotein convertases | |||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 95 ↔ 113 | |||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 71 | 1 | S → G in HFTC; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex. Ref.12 | VAR_023831 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 176 | 1 | R → Q in ADHR. Ref.2 | VAR_010717 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 179 | 1 | R → Q in ADHR; C-terminal processing is abolished. Ref.2 | VAR_010719 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 179 | 1 | R → W in ADHR; C-terminal processing is abolished. Ref.2 | VAR_010718 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 195 | 1 | P → S: dbSNP rs13312793. Ref.5 | VAR_018887 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 239 | 1 | T → M: dbSNP rs7955866. Ref.2 Ref.5 | VAR_010720 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 40 – 43 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 47 – 49 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 55 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 61 – 66 | 6 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 69 – 71 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 77 | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 79 – 81 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 82 – 87 | 6 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 88 – 91 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 92 – 96 | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 102 – 107 | 6 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 110 – 112 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 115 – 119 | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 125 – 128 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 130 – 132 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 138 – 140 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 153 – 155 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 157 – 161 | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 166 – 168 | 3 | ||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain." Yamashita T., Yoshioka M., Itoh N. Biochem. Biophys. Res. Commun. 277:494-498(2000) [PubMed: 11032749] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23." White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J., Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M. Nat. Genet. 26:345-348(2000) [PubMed: 11062477] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ADHR GLN-176; GLN-179 AND TRP-179, VARIANT MET-239. |
| [3] | "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia." Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T. Proc. Natl. Acad. Sci. U.S.A. 98:6500-6505(2001) [PubMed: 11344269] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | NIEHS SNPs program Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-195 AND MET-239. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [7] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed: 15340161] [Abstract] Cited for: PROTEIN SEQUENCE OF 25-39. |
| [8] | "The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting." White K.E., Jonsson K.B., Carn G., Hampson G., Spector T.D., Mannstadt M., Lorenz-Depiereux B., Miyauchi A., Yang I.M., Ljunggren O., Meitinger T., Strom T.M., Jueppner H., Econs M.J. J. Clin. Endocrinol. Metab. 86:497-500(2001) [PubMed: 11157998] [Abstract] Cited for: PROCESSING. |
| [9] | "Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo." Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T. Endocrinology 143:3179-3182(2002) [PubMed: 12130585] [Abstract] Cited for: PROCESSING. |
| [10] | "FGF23 is processed by proprotein convertases but not by PHEX." Benet-Pages A., Lorenz-Depiereux B., Zischka H., White K.E., Econs M.J., Strom T.M. Bone 35:455-462(2004) [PubMed: 15268897] [Abstract] Cited for: PROCESSING BY PROPROTEIN CONVERTASES. |
| [11] | "Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members." Goetz R., Beenken A., Ibrahimi O.A., Kalinina J., Olsen S.K., Eliseenkova A.V., Xu C., Neubert T.A., Zhang F., Linhardt R.J., Yu X., White K.E., Inagaki T., Kliewer S.A., Yamamoto M., Kurosu H., Ogawa Y., Kuro-o M. Mohammadi M.Mol. Cell. Biol. 27:3417-3428(2007) [PubMed: 17339340] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 25-179. |
| [12] | "An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia." Benet-Pages A., Orlik P., Strom T.M., Lorenz-Depiereux B. Hum. Mol. Genet. 14:385-390(2005) [PubMed: 15590700] [Abstract] Cited for: VARIANT HFTC GLY-71. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AB037973 mRNA. Translation: BAB13477.1. AF263537 mRNA. Translation: AAG09917.1. AB047858 mRNA. Translation: BAB55889.1. AY358323 mRNA. Translation: AAQ88689.1. AY566236 Genomic DNA. Translation: AAS59157.1. BC069333 mRNA. Translation: AAH69333.1. BC096713 mRNA. Translation: AAH96713.1. BC098147 mRNA. Translation: AAH98147.1. BC098252 mRNA. Translation: AAH98252.1. | |||||||||||||
| IPI | IPI00026407. | ||||||||||||
| RefSeq | NP_065689.1. | ||||||||||||
| UniGene | Hs.287370 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q9GZV9. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000118972. Homo sapiens. [Contig view] | ||||||||||||
| GeneID | 8074. | ||||||||||||
| KEGG | hsa:8074. | ||||||||||||
| NMPDR | fig|9606.3.peg.6984. | ||||||||||||
Organism-specific databases | |||||||||||||
| GeneCards | GC12M004347. | ||||||||||||
| H-InvDB | HIX0036668. | ||||||||||||
| HGNC | HGNC:3680. FGF23. | ||||||||||||
| MIM | 193100. phenotype. 211900. phenotype. 605380. gene. | ||||||||||||
| Orphanet | 53715. Calcinosis, tumoral. 437. Vitamin D resistant rickets. | ||||||||||||
| PharmGKB | PA28119. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | Q9GZV9. | ||||||||||||
| HOVERGEN | Q9GZV9. | ||||||||||||
| OMA | Q9GZV9. ASDPLGV. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | fgf_pathway. FGF signaling pathway. | ||||||||||||
| Reactome | REACT_9470. Signaling by FGFR. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9GZV9. | ||||||||||||
| Bgee | Q9GZV9. | ||||||||||||
| CleanEx | HS_FGF23. | ||||||||||||
| GermOnline | ENSG00000118972. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR002348. IL1_HBGF. [Graphical view] | ||||||||||||
| PANTHER | PTHR11486. IL1_HBGF. 1 hit. | ||||||||||||
| Pfam | PF00167. FGF. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00262. IL1HBGF. | ||||||||||||
| ProDom | PD000831. IL1_HBGF. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00442. FGF. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00247. HBGF_FGF. False negative. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 30678. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | FGF23_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9GZV9 Secondary accession number(s): Q4V758 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


